The essentials
Trump nominates new CDC director after months of leadership vacancies and turnover.
Trump has nominated Dr. Erica Schwartz as CDC director, following months of instability at the federal health agency. The CDC has operated without a permanent director since August 2025, relying on acting leadership during a period of significant organizational change.
Acting director Susan Monarez was ousted after just one month in the role, marking another disruption in the agency's top leadership. Her departure came as Dr. David Weldon's confirmation hearing was canceled, further complicating efforts to establish permanent directorship.
The repeated leadership transitions reflect ongoing challenges in filling the critical position. The timing underscores broader questions about continuity and stability at an agency responsible for disease prevention and public health response.
Other ways to read this story.
Alternative framings generated by SigNews. These are not independent sources or attributed quotations.
CDC director position vacant since August, multiple leadership transitions
The agency has cycled through leadership since August 2025. Acting director Susan Monarez lasted one month before her removal, followed by cancellation of Dr. David Weldon's confirmation hearing. Trump's nomination of Dr. Erica Schwartz represents the latest effort to fill the position. This succession of changes reflects the operational challenges of extended vacancy periods.
Repeated director changes raise questions about agency continuity
Seven-month directorship vacancy and monthly acting leadership turnover pose challenges for CDC operations. The cancellation of Weldon's confirmation hearing alongside Monarez's sudden ouster suggests difficulties in stabilizing the position. Schwartz's nomination signals an attempt to establish permanent, confirmed leadership after a period marked by short-term appointments and administrative disruption.